Adverum Biotechnologies, Inc. (LON:0HA3)
2.975
-0.034 (-1.12%)
At close: Sep 17, 2025
Adverum Biotechnologies Employees
Adverum Biotechnologies had 155 employees as of December 31, 2024. The number of employees increased by 34 or 28.10% compared to the previous year.
Employees
155
Change (1Y)
34
Growth (1Y)
28.10%
Revenue / Employee
4.71K GBP
Profits / Employee
-798.14K GBP
Market Cap
44.24M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 155 | 34 | 28.10% |
Dec 31, 2023 | 121 | -2 | -1.63% |
Dec 31, 2022 | 123 | -65 | -34.57% |
Dec 31, 2021 | 188 | 21 | 12.57% |
Dec 31, 2020 | 167 | 53 | 46.49% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
HSBC Holdings | 211,304 |
Shell | 96,000 |
Unilever | 115,964 |
Rolls-Royce Holdings | 42,400 |
British American Tobacco p.l.c. | 48,989 |
Rio Tinto Group | 60,000 |
BP p.l.c. | 100,500 |
Adverum Biotechnologies News
- 6 weeks ago - Adverum Biotechnologies to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 3 months ago - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Adverum Biotechnologies GAAP EPS of -$2.25 misses by $0.31 - Seeking Alpha
- 4 months ago - Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights - GlobeNewsWire
- 4 months ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - Accesswire
- 4 months ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - GlobeNewsWire
- 4 months ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - Accesswire
- 4 months ago - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire